BenevolentAI

In News

BenevolentAI And AstraZeneca Collaborate On New Lupus Target Sam O'reilly (hNAB4pTc9p) - Mshale

Mshale - Jul 29, 2026

Amyotrophic Lateral Sclerosis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX - Barchart.com

Barchart.com - Jun 17, 2026

BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission - Business Wire

Business Wire - Dec 11, 2024

Merck KGaA links with BenevolentAI and Exscientia to expand AI capabilities - Pharmaceutical Technology

Pharmaceutical Technology - Sep 20, 2023

BenevolentAI, cruel R&D: AI-enabled drug flunks midphase eczema trial to dent deal plans - Fierce Biotech

Fierce Biotech - Apr 05, 2023

The AI drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technology’s limits - Fortune

Fortune - Sep 12, 2025

BenevolentAI restructures; Lilly preps $15B buyback program - biopharmadive.com

biopharmadive.com - Dec 11, 2024

BenevolentAI exploring novel AI-driven drug discovery methods - drugdiscoverytrends.com

drugdiscoverytrends.com - May 03, 2023

Latham Advises BenevolentAI on €1.5 Billion Business Combination With Odyssey - Latham & Watkins LLP

Latham & Watkins LLP - Apr 27, 2022

Britain in danger of outsourcing its intellect, warns AI pioneer - The Telegraph

The Telegraph - Dec 14, 2025

Mulvany hits the reset button at BenevolentAI - pharmaphorum

pharmaphorum - Dec 11, 2024

Inconclusive efficacy of BenevolentAI’s AD drug leaves the company guessing - Clinical Trials Arena

Clinical Trials Arena - Apr 05, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment